Nanoparticulate systems for the delivery of antisense oligonucleotides

被引:152
作者
Lambert, G [1 ]
Fattal, E [1 ]
Couvreur, P [1 ]
机构
[1] Fac Pharm Chatenay Malabry, URA CNRS 8612, Lab Phys Chim Pharmacotech & Biopharm, F-92296 Chatenay Malabry, France
关键词
nanoparticles; nanocapsules; nanospheres; oligonucleotide; antisense;
D O I
10.1016/S0169-409X(00)00116-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Antisense oligonucleotides are molecules that are able to inhibit gene expression being therefore potentially active for the treatment of viral infections or cancer, However, because of their poor stability in biological medium and their weak intracellular penetration, colloidal drugs carriers such as nanoparticles were developed for the delivery of oligonucleotides (ODN). ODN associated to nanoparticles were shown to be protected against degradation and to penetrate more easily into different types of cells. As a consequence, nanoparticles were shown to improve the efficiency of ODNs for the inhibition of the proliferation of cells expressing the point mutated Ha-ras gene. In vivo, polyalkylcyanoacrylate (PACA) nanoparticles were able to efficiently distribute the ODNs to the liver whereas the alginate nanosponges could concentrate the ODNs in the lungs. Finally, ODN loaded to PACA nanoparticles were able to improve in mice, the treatment of RAS cells expressing the point mutated Ha-ras gene, (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:99 / 112
页数:14
相关论文
共 73 条
[51]   PREPARATION AND CHARACTERIZATION OF NOVEL POLY(METHYLIDENE MALONATE 2.1.2.)-MADE NANOPARTICLES [J].
LESCURE, F ;
SEGUIN, C ;
BRETON, P ;
BOURRINET, P ;
ROY, D ;
COUVREUR, P .
PHARMACEUTICAL RESEARCH, 1994, 11 (09) :1270-1277
[52]   CHARACTERIZATION OF OLIGONUCLEOTIDE TRANSPORT INTO LIVING CELLS [J].
LOKE, SL ;
STEIN, CA ;
ZHANG, XH ;
MORI, K ;
NAKANISHI, M ;
SUBASINGHE, C ;
COHEN, JS ;
NECKERS, LM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (10) :3474-3478
[53]   DEVELOPMENT OF POLY (DIALKYL METHYLIDENEMALONATE) NANOPARTICLES AS DRUG CARRIERS [J].
MBELA, TKM ;
POUPAERT, JH ;
DUMONT, P ;
HAEMERS, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 92 (1-3) :71-79
[54]   TRIPLE HELIX SPECIFIC LIGANDS [J].
MERGNY, JL ;
DUVALVALENTIN, G ;
NGUYEN, CH ;
PERROUAULT, L ;
FAUCON, B ;
ROUGEE, M ;
MONTENAYGARESTIER, T ;
BISAGNI, E ;
HELENE, C .
SCIENCE, 1992, 256 (5064) :1681-1684
[55]   Pharmacokinetics and biodistribution of oligonucleotide adsorbed onto poly(isobutylcyanoacrylate) nanoparticles after intravenous administration in mice [J].
Nakada, Y ;
Fattal, E ;
Foulquier, M ;
Couvreur, P .
PHARMACEUTICAL RESEARCH, 1996, 13 (01) :38-43
[56]   STERICALLY STABILIZED LIPOSOMES - IMPROVEMENTS IN PHARMACOKINETICS AND ANTITUMOR THERAPEUTIC EFFICACY [J].
PAPAHADJOPOULOS, D ;
ALLEN, TM ;
GABIZON, A ;
MAYHEW, E ;
MATTHAY, K ;
HUANG, SK ;
LEE, KD ;
WOODLE, MC ;
LASIC, DD ;
REDEMANN, C ;
MARTIN, FJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) :11460-11464
[57]   Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles [J].
Peracchia, MT ;
Vauthier, C ;
Passirani, C ;
Couvreur, P ;
Labarre, D .
LIFE SCIENCES, 1997, 61 (07) :749-761
[58]  
Peracchia MT, 1997, J BIOMED MATER RES, V34, P317, DOI 10.1002/(SICI)1097-4636(19970305)34:3<317::AID-JBM6>3.0.CO
[59]  
2-N
[60]   STABILITY AND PROPERTIES OF DOUBLE AND TRIPLE HELICES - DRAMATIC EFFECTS OF RNA OR DNA BACKBONE COMPOSITION [J].
ROBERTS, RW ;
CROTHERS, DM .
SCIENCE, 1992, 258 (5087) :1463-1466